74th Indian Pharmaceutical Congress 2025 Opens Registrations

India Pharma Outlook Team | Monday, 19 May 2025

The Indian Pharmaceutical Congress, 2025 (IPC), which is organized by the Association of Pharmaceutical Teachers of India (APTI), has opened its registration. The conference will take place from 19th to 21st December, 2025 at the Bangalore International Exhibition Centre (BIEC), Bengaluru. Participants may enroll in four phases; Super Saver (May 15 to July 14), Early Bird (July 15 to September 14), Regular (September 15 to November 14), and Spot Registration on the opening day. Registration categories are Students, Teachers and Members of APTI, IPA, IPGA, IHPA, AIDCOC, Non-Members, Accompanying Persons, and Foreign Delegates.

Key Takeaways:

Registrations are now open for the 74th Indian Pharmaceutical Congress 2025, to be held from December 19 to 21 at BIEC, Bengaluru.
Discounted registration fees are available for members of APTI and affiliated associations.
Fees vary by category and registration phase, with the Super Saver window open until July 14, 2025.

Also read: https://www.indiapharmaoutlook.com/news/how-the-transition-from-treatment-to-prevention-is-changing-the-pharma-industry-nwid-184.html

For students, the charge is Rs 40,000 for Super Saver and Rs 50,000 for Regular registration. Teachers and members of an association will remit Rs 55,000 for Super Saver, Rs 65,000 for Early Bird, Rs 75,000 for Regular, and Rs 85,000 for Spot Registration. Non-Members need to pay Rs 70,000 for Super Saver, Rs 80,000 for Early Bird, Rs 90,000 for Regular, and Rs 1,00,000 for Spot Registration. Accompanying persons are assessed Rs 40,000 under Super Saver, going up to Rs 55,000 for Spot Registration. Foreign delegates need to pay USD 150 under Super Saver, USD 200 under Early Bird, USD 250 for Regular, and USD 300 for Spot Registration.

APTI has made it clear that discounted registration rates are reserved for its institutional and individual members. Non-members can apply right away to be able to enjoy these privileges. The Congress assures to be a very important platform for networking, exchange of knowledge, and cooperation among pharmaceutical experts and academicians.